Advertisement

Topics

Biomarkers to Determine Who Gets Checkpoint Inhibitors

09:04 EDT 3 Apr 2017 | Medscape

Reviewing recent research, Dr Jeffrey Weber concludes that an amalgam of host- and tumor-related markers will be the best indication of which patients should receive checkpoint inhibitors.
Medscape Oncology

Original Article: Biomarkers to Determine Who Gets Checkpoint Inhibitors

NEXT ARTICLE

More From BioPortfolio on "Biomarkers to Determine Who Gets Checkpoint Inhibitors"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...